臨床試験管理システムの市場規模、シェア、動向分析レポート：ソリューションタイプ別、デリバリーモード別、コンポーネント別、エンドユーザー別、地域別、セグメント予測、2024年～2030年

臨床試験管理システム市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の臨床試験管理システム市場規模は2030年までに47億3,000万米ドルに達すると予測され、2024年から2030年までのCAGRは14.65％で成長すると予測されています。

臨床試験件数の増加、バーチャル臨床試験や分散型臨床試験の増加、eClinicalソリューションに対する需要の高まりなどが市場成長の要因となっています。

ライフサイエンス企業の研究開発投資の増加や急性・慢性疾患の流行は、患者の転帰の改善を目的とした臨床試験の急増に寄与しています。例えば、ClinicalTrials.govでは、糖尿病に関する653件の有効な臨床試験が報告されており、複数の臨床試験を効率的に管理するための臨床試験管理（CTM）システムのようなソリューションに対する需要が大きいことを示しています。

複数の市場プレーヤーが、DCTとその要件に合わせてカスタマイズしたソリューションを発表したり、既存のソリューションを最適化したりしています。例えば、Cloudbyzの分散型CTMソリューションは、ePRO、リモートモニタリング＆SDV、eConsent、eCRF、EDC、eCOA、eDiary、バーチャルPR、eTMFなどのさまざまな機能を提供するクラウドベースのCTMソリューションで、バーチャル試験をサポートしています。2022年現在、同市場の主要プレーヤーであるParexel International Corporationは、250件以上の完全バーチャルまたはハイブリッドDCTを実施し、200件以上のリモート患者エンゲージメント戦略（患者募集、e-visits、リテンションプラットフォームなど）を臨床試験に組み込んだ実績があります。

臨床試験管理システム市場レポートハイライト

• ヘルスケアITの急成長、臨床試験件数の増加、CTMSソリューションの採用拡大、先進国・新興国双方の臨床研究に対する政府支援などが市場を牽引。
• ソリューションの種類別では、エンタープライズ分野が2023年に74.35%の最大売上シェアで市場をリードしました。その主なメリットは、逸脱・未収に関するエンドツーエンドの洞察の提供、堅牢なレポーティング、ソリューションの拡張性、規制プロセスの追跡・管理、請求コンプライアンスの強化などです。
• コンポーネント別では、ソフトウェア・セグメントが2023年に56.04％の最大売上シェアで市場をリードしました。これは、臨床試験の管理と重要な機能の実行を支援する使いやすいツールであるためです。
• 提供形態別では、ウェブ＆クラウド分野が2023年に56.04％の最大売上シェアで市場をリードしました。
• 最終用途別では、提携の増加、CROへの臨床試験アウトソーシング、臨床試験数の分散化により、CROおよびその他セグメントが2023年に40.16%の最大収益シェアで市場を占めました。
• 北米は2023年に50.01%の収益シェアで市場を独占したが、これは技術的進歩、同地域における市場プレイヤーの強力なプレゼンス、臨床試験分野における技術進歩、臨床試験を促進するための政府の支援政策によるものです。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 臨床試験管理システム市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場牽引要因分析
  • 市場抑制要因分析
• 臨床試験管理システム市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析

第4章 臨床試験管理システム市場：ソリューションタイプの推定・動向分析

• ソリューションタイプの市場シェア、2023年および2030年
• セグメントダッシュボード
• 世界の臨床試験管理システム市場、ソリューションタイプ別展望
• 記述的分析
• 企業
• サイト

第5章 臨床試験管理システム市場：コンポーネントの推定・動向分析

• コンポーネント市場シェア、2023年および2030年
• セグメントダッシュボード
• 世界の臨床試験管理システム市場、コンポーネント別展望
• ソフトウェア
• サービス

第6章 臨床試験管理システム市場：提供モードの推定・動向分析

• 提供モードの市場シェア、2023年および2030年
• セグメントダッシュボード
• 世界の臨床試験管理システム市場、提供モード別展望
• オンプレミス
• ウェブとクラウドベース

第7章 臨床試験管理システム市場：エンドユーザーの推定・動向分析

• アプリケーション市場シェア、2023年および2030年
• セグメントダッシュボード
• アプリケーション別世界臨床試験管理システム市場展望
• 製薬・バイオテクノロジー企業
• 医療機器企業
• CROおよびその他

第8章 臨床試験管理システム市場：地域推定・動向分析、ソリューションタイプ別、コンポーネント別、配信モード別、最終用途別

• 地域別市場シェア分析、2023年および2030年
• 地域市場ダッシュボード
• 世界地域市場スナップショット
• 市場規模と予測トレンド分析、2018年から2030年
• 北米
• 欧州
• アジア太平洋地域
• ラテンアメリカ
• 中東・アフリカ

第9章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 企業/競合の分類
  • イノベーター
• ベンダー情勢
  • 主要ディストリビューターおよびチャネルパートナーのリスト
  • 主要顧客
  • 主要企業の市場シェア分析、2023年
  • IQVIA, Inc.
  • Medidata（Dassault Systemes）
  • Oracle
  • DATATRAK International, Inc.
  • Clario
  • SimpleTrials
  • Calyx（formerly Parexel Informatics）
  • RealTime Software Solutions, LLC
  • Laboratory Corporation of America Holdings
  • Veeva Systems
  • Wipro Limited
  • PHARMASEAL International Ltd

List of Tables

• Table 1 List of abbreviation
• Table 2 North America clinical trials management system market, by region, 2018 - 2030 (USD Million)
• Table 3 North America clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
• Table 4 North America clinical trials management system market, by component, 2018 - 2030 (USD Million)
• Table 5 North America clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
• Table 6 North America clinical trials management system market, by end use, 2018 - 2030 (USD Million)
• Table 7 U.S. clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
• Table 8 U.S. clinical trials management system market, by component, 2018 - 2030 (USD Million)
• Table 9 U.S. clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
• Table 10 U.S. clinical trials management system market, by end use, 2018 - 2030 (USD Million)
• Table 11 Canada clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
• Table 12 Canada clinical trials management system market, by component, 2018 - 2030 (USD Million)
• Table 13 Canada clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
• Table 14 Canada clinical trials management system market, by end use, 2018 - 2030 (USD Million)
• Table 15 Europe clinical trials management system market, by region, 2018 - 2030 (USD Million)
• Table 16 Europe clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
• Table 17 Europe clinical trials management system market, by component, 2018 - 2030 (USD Million)
• Table 18 Europe clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
• Table 19 Europe clinical trials management system market, by end use, 2018 - 2030 (USD Million)
• Table 20 Germany clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
• Table 21 Germany clinical trials management system market, by component, 2018 - 2030 (USD Million)
• Table 22 Germany clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
• Table 23 Germany clinical trials management system market, by end use, 2018 - 2030 (USD Million)
• Table 24 U.K. clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
• Table 25 U.K. clinical trials management system market, by component, 2018 - 2030 (USD Million)
• Table 26 U.K. clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
• Table 27 U.K. clinical trials management system market, by end use, 2018 - 2030 (USD Million)
• Table 28 France clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
• Table 29 France clinical trials management system market, by component, 2018 - 2030 (USD Million)
• Table 30 France clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
• Table 31 France clinical trials management system market, by end use, 2018 - 2030 (USD Million)
• Table 32 Italy clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
• Table 33 Italy clinical trials management system market, by component, 2018 - 2030 (USD Million)
• Table 34 Italy clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
• Table 35 Italy clinical trials management system market, by end use, 2018 - 2030 (USD Million)
• Table 36 Spain clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
• Table 37 Spain clinical trials management system market, by component, 2018 - 2030 (USD Million)
• Table 38 Spain clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
• Table 39 Spain clinical trials management system market, by end use, 2018 - 2030 (USD Million)
• Table 40 Denmark clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
• Table 41 Denmark clinical trials management system market, by component, 2018 - 2030 (USD Million)
• Table 42 Denmark clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
• Table 43 Denmark clinical trials management system market, by end use, 2018 - 2030 (USD Million)
• Table 44 Sweden clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
• Table 45 Sweden clinical trials management system market, by component, 2018 - 2030 (USD Million)
• Table 46 Sweden clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
• Table 47 Sweden clinical trials management system market, by end use, 2018 - 2030 (USD Million)
• Table 48 Norway clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
• Table 49 Norway clinical trials management system market, by component, 2018 - 2030 (USD Million)
• Table 50 Norway clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
• Table 51 Norway clinical trials management system market, by end use, 2018 - 2030 (USD Million)
• Table 52 Asia Pacific clinical trials management system market, by region, 2018 - 2030 (USD Million)
• Table 53 Asia Pacific clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
• Table 54 Asia Pacific clinical trials management system market, by component, 2018 - 2030 (USD Million)
• Table 55 Asia Pacific clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
• Table 56 Asia Pacific clinical trials management system market, by end use, 2018 - 2030 (USD Million)
• Table 57 China clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
• Table 58 China clinical trials management system market, by component, 2018 - 2030 (USD Million)
• Table 59 China clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
• Table 60 China clinical trials management system market, by end use, 2018 - 2030 (USD Million)
• Table 61 Japan clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
• Table 62 Japan clinical trials management system market, by component, 2018 - 2030 (USD Million)
• Table 63 Japan clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
• Table 64 Japan clinical trials management system market, by end use, 2018 - 2030 (USD Million)
• Table 65 India clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
• Table 66 India clinical trials management system market, by component, 2018 - 2030 (USD Million)
• Table 67 India clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
• Table 68 India clinical trials management system market, by end use, 2018 - 2030 (USD Million)
• Table 69 South Korea clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
• Table 70 South Korea clinical trials management system market, by component, 2018 - 2030 (USD Million)
• Table 71 South Korea clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
• Table 72 South Korea clinical trials management system market, by end use, 2018 - 2030 (USD Million)
• Table 73 Australia clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
• Table 74 Australia clinical trials management system market, by component, 2018 - 2030 (USD Million)
• Table 75 Australia clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
• Table 76 Australia clinical trials management system market, by end use, 2018 - 2030 (USD Million)
• Table 77 Thailand clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
• Table 78 Thailand clinical trials management system market, by component, 2018 - 2030 (USD Million)
• Table 79 Thailand clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
• Table 80 Thailand clinical trials management system market, by end use, 2018 - 2030 (USD Million)
• Table 81 Latin America clinical trials management system market, by region, 2018 - 2030 (USD Million)
• Table 82 Latin America clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
• Table 83 Latin America clinical trials management system market, by component, 2018 - 2030 (USD Million)
• Table 84 Latin America clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
• Table 85 Latin America clinical trials management system market, by end use, 2018 - 2030 (USD Million)
• Table 86 Brazil clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
• Table 87 Brazil clinical trials management system market, by component, 2018 - 2030 (USD Million)
• Table 88 Brazil clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
• Table 89 Brazil clinical trials management system market, by end use, 2018 - 2030 (USD Million)
• Table 90 Mexico clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
• Table 91 Mexico clinical trials management system market, by component, 2018 - 2030 (USD Million)
• Table 92 Mexico clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
• Table 93 Mexico clinical trials management system market, by end use, 2018 - 2030 (USD Million)
• Table 94 Argentina clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
• Table 95 Argentina clinical trials management system market, by component, 2018 - 2030 (USD Million)
• Table 96 Argentina clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
• Table 97 Argentina clinical trials management system market, by end use, 2018 - 2030 (USD Million)
• Table 98 MEA clinical trials management system market, by region, 2018 - 2030 (USD Million)
• Table 99 MEA clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
• Table 100 MEA clinical trials management system market, by component, 2018 - 2030 (USD Million)
• Table 101 MEA clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
• Table 102 MEA clinical trials management system market, by end use, 2018 - 2030 (USD Million)
• Table 103 South Africa clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
• Table 104 South Africa clinical trials management system market, by component, 2018 - 2030 (USD Million)
• Table 105 South Africa clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
• Table 106 South Africa clinical trials management system market, by end use, 2018 - 2030 (USD Million)
• Table 107 Saudi Arabia clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
• Table 108 Saudi Arabia clinical trials management system market, by component, 2018 - 2030 (USD Million)
• Table 109 Saudi Arabia clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
• Table 110 Saudi Arabia clinical trials management system market, by end use, 2018 - 2030 (USD Million)
• Table 111 UAE clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
• Table 112 UAE clinical trials management system market, by component, 2018 - 2030 (USD Million)
• Table 113 UAE clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
• Table 114 UAE clinical trials management system market, by end use, 2018 - 2030 (USD Million)
• Table 115 Kuwait clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
• Table 116 Kuwait clinical trials management system market, by component, 2018 - 2030 (USD Million)
• Table 117 Kuwait clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
• Table 118 Kuwait clinical trials management system market, by end use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 Value-chain-based sizing & forecasting
• Fig. 6 QFD modeling for market share assessment
• Fig. 7 Market formulation & validation
• Fig. 8 Clinical trials management system market: market outlook
• Fig. 9 Clinical trials management system competitive insights
• Fig. 10 Parent market outlook
• Fig. 11 Related/ancillary market outlook
• Fig. 12 Penetration and growth prospect mapping
• Fig. 13 Industry value chain analysis
• Fig. 14 Clinical trials management system market driver impact
• Fig. 15 Clinical trials management system market restraint impact
• Fig. 16 Clinical trials management system market strategic initiatives analysis
• Fig. 17 Clinical trials management system market: Solution type movement analysis
• Fig. 18 Clinical trials management system market: Solution type outlook and key takeaways
• Fig. 19 Descriptive analysis market estimates and forecast, 2018 - 2030
• Fig. 20 Enterprise market estimates and forecast, 2018 - 2030
• Fig. 21 Site market estimates and forecast, 2018 - 2030
• Fig. 22 Clinical trials management system market: Component movement analysis
• Fig. 23 Clinical trials management system market: Component outlook and key takeaways
• Fig. 24 Software market estimates and forecast, 2018 - 2030
• Fig. 25 Services market estimates and forecast, 2018 - 2030
• Fig. 26 Clinical trials management system market: Delivery mode movement analysis
• Fig. 27 Clinical trials management system market: Delivery mode outlook and key takeaways
• Fig. 28 On-premise systems market estimates and forecast, 2018 - 2030
• Fig. 29 Web & cloud-based systems market estimates and forecast, 2018 - 2030
• Fig. 30 Clinical trials management system market: End user movement analysis
• Fig. 31 Clinical trials management system market: End user outlook and key takeaways
• Fig. 32 Pharmaceutical and biotechnology firms market estimates and forecast, 2018 - 2030
• Fig. 33 Medical device firms market estimates and forecast, 2018 - 2030
• Fig. 34 CROs & others market estimates and forecast, 2018 - 2030
• Fig. 35 Global clinical trials management system market: Regional movement analysis
• Fig. 36 Global clinical trials management system market: Regional outlook and key takeaways
• Fig. 37 Global clinical trials management system market share and leading players
• Fig. 38 North America market share and leading players
• Fig. 39 Europe market share and leading players
• Fig. 40 Asia Pacific market share and leading players
• Fig. 41 Latin America market share and leading players
• Fig. 42 Middle East & Africa market share and leading players
• Fig. 43 North America: SWOT
• Fig. 44 Europe SWOT
• Fig. 45 Asia Pacific SWOT
• Fig. 46 Latin America SWOT
• Fig. 47 MEA SWOT
• Fig. 48 North America
• Fig. 49 North America market estimates and forecasts, 2018 - 2030
• Fig. 50 US
• Fig. 51 US market estimates and forecasts, 2018 - 2030
• Fig. 52 Canada
• Fig. 53 Canada market estimates and forecasts, 2018 - 2030
• Fig. 54 Europe
• Fig. 55 Europe market estimates and forecasts, 2018 - 2030
• Fig. 56 UK
• Fig. 57 UK market estimates and forecasts, 2018 - 2030
• Fig. 58 Germany
• Fig. 59 Germany market estimates and forecasts, 2018 - 2030
• Fig. 60 France
• Fig. 61 France market estimates and forecasts, 2018 - 2030
• Fig. 62 Italy
• Fig. 63 Italy market estimates and forecasts, 2018 - 2030
• Fig. 64 Spain
• Fig. 65 Spain market estimates and forecasts, 2018 - 2030
• Fig. 66 Denmark
• Fig. 67 Denmark market estimates and forecasts, 2018 - 2030
• Fig. 68 Sweden
• Fig. 69 Sweden market estimates and forecasts, 2018 - 2030
• Fig. 70 Norway
• Fig. 71 Norway market estimates and forecasts, 2018 - 2030
• Fig. 72 Asia Pacific
• Fig. 73 Asia Pacific market estimates and forecasts, 2018 - 2030
• Fig. 74 China
• Fig. 75 China market estimates and forecasts, 2018 - 2030
• Fig. 76 Japan
• Fig. 77 Japan market estimates and forecasts, 2018 - 2030
• Fig. 78 India
• Fig. 79 India market estimates and forecasts, 2018 - 2030
• Fig. 80 Thailand
• Fig. 81 Thailand market estimates and forecasts, 2018 - 2030
• Fig. 82 South Korea
• Fig. 83 South Korea market estimates and forecasts, 2018 - 2030
• Fig. 84 Australia
• Fig. 85 Australia market estimates and forecasts, 2018 - 2030
• Fig. 86 Latin America
• Fig. 87 Latin America market estimates and forecasts, 2018 - 2030
• Fig. 88 Brazil
• Fig. 89 Brazil market estimates and forecasts, 2018 - 2030
• Fig. 90 Mexico
• Fig. 91 Mexico market estimates and forecasts, 2018 - 2030
• Fig. 92 Argentina
• Fig. 93 Argentina market estimates and forecasts, 2018 - 2030
• Fig. 94 Middle East and Africa
• Fig. 95 Middle East and Africa market estimates and forecasts, 2018 - 2030
• Fig. 96 South Africa
• Fig. 97 South Africa market estimates and forecasts, 2018 - 2030
• Fig. 98 Saudi Arabia
• Fig. 99 Saudi Arabia market estimates and forecasts, 2018 - 2030
• Fig. 100 UAE
• Fig. 101 UAE market estimates and forecasts, 2018 - 2030
• Fig. 102 Kuwait
• Fig. 103 Kuwait market estimates and forecasts, 2018 - 2030
• Fig. 104 Market share of key market players- Clinical trials management system market

Clinical Trials Management System Market Growth & Trends:

The global clinical trials management system market size is anticipated to reach USD 4.73 billion by 2030 and is projected to grow at a CAGR of 14.65% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing number of clinical trials, a rise in virtual or decentralized clinical trials, and the growing demand for eClinical solutions are some of the factors contributing to the market growth.

Life science companies' rising R&D investments and the prevalence of acute and chronic disorders contribute to the surge in clinical trials aimed at enhancing patient outcomes. For instance, ClinicalTrials.gov reports 653 active clinical trials on diabetes, indicating a significant demand for solutions like Clinical Trial Management (CTM) systems to efficiently manage multiple trials.

Several market players are launching tailored solutions or optimizing existing solutions to fit DCTs and their requirements. For example, the decentralized CTM Solution by Cloudbyz offers a cloud-based CTM solution that offers a range of features such as ePRO, remote monitoring & SDV, eConsent, eCRF, EDC, eCOA, eDiary, virtual PR, and eTMF to support virtual trials. As of 2022, Parexel International Corporation, a key player in the market, conducted over 250 fully virtual or hybrid DCTs and has experience with over 200 remote patient engagement strategies, e.g., patient recruitment, e-visits, and retention platforms, incorporated into trials.

Clinical Trials Management System Market Report Highlights:

• The market is primarily driven by rapid growth of healthcare IT, rise in the number of clinical trials, increased adoption of CTMS solutions, and government support for clinical research in both developed & developing countries
• Based on solution type, the enterprise segment led the market with the largest revenue share of 74.35% in 2023, owing to its key benefits, such as offering end-to-end insights into deviations & accruals, robust reporting, scalability of solutions, tracking & managing regulatory processes, and enhanced billing compliance
• Based on component, the software segment led the market with the largest revenue share of 56.04% in 2023, due to it being an easy-to-use tool that helps manage clinical trials and perform critical functions
• Based on delivery mode, web & cloud segment led the market with the largest revenue share of 56.04% in 2023, due to its increased adoption by end users
• Based on end user, the CRO and others segment held the market with the largest revenue share of 40.16% in 2023, owing to the increasing number of partnerships, clinical trial outsourcing to CROs, and decentralized trial counts
• North America dominated the market with a revenue share of 50.01% in 2023, owing to the technological advancements, strong presence of market players in the regions, technological advancement in the field of clinical trials, and supportive government policies to promote clinical trials

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Solution Type
  • 1.1.2. Component
  • 1.1.3. Delivery mode
  • 1.1.4. End user
  • 1.1.5. Regional scope
  • 1.1.6. Estimates and forecast timeline.
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database.
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
  • 1.6.2. Approach 1: Commodity flow approach
  • 1.6.3. Volume price analysis (Model 2)
  • 1.6.4. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Solution type outlook
  • 2.2.2. Component outlook
  • 2.2.3. Delivery mode outlook
  • 2.2.4. End user outlook
  • 2.2.5. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Clinical Trials Management System Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
• 3.3. Clinical Trials Management System Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Clinical Trials Management System Market: Solution Type Estimates & Trend Analysis

• 4.1. Solution Type Market Share, 2023 & 2030
• 4.2. Segment Dashboard
• 4.3. Global Clinical Trials Management System Market, by Solution Type Outlook
• 4.4. Descriptive Analysis
  • 4.4.1. Market estimates and forecast, 2018 to 2030 (USD Million)
• 4.5. Enterprise
  • 4.5.1. Market estimates and forecast, 2018 to 2030 (USD Million)
• 4.6. Site
  • 4.6.1. Market estimates and forecast, 2018 to 2030 (USD Million)

Chapter 5. Clinical Trials Management System Market: Component Estimates & Trend Analysis

• 5.1. Component Market Share, 2023 & 2030
• 5.2. Segment Dashboard
• 5.3. Global Clinical Trials Management System Market, by Component Outlook
• 5.4. Software
  • 5.4.1. Market estimates and forecast, 2018 to 2030 (USD Million)
• 5.5. Services
  • 5.5.1. Market estimates and forecast, 2018 to 2030 (USD Million)

Chapter 6. Clinical Trials Management System Market: Delivery Mode Estimates & Trend Analysis

• 6.1. Delivery Modes Market Share, 2023 & 2030
• 6.2. Segment Dashboard
• 6.3. Global Clinical Trials Management System Market, by Delivery Modes Outlook
• 6.4. On-Premises
  • 6.4.1. Market estimates and forecast, 2018 to 2030 (USD Million)
• 6.5. Web & Cloud-Based
  • 6.5.1. Market estimates and forecast, 2018 to 2030 (USD Million)

Chapter 7. Clinical Trials Management System Market: End-user Estimates & Trend Analysis

• 7.1. Application Market Share, 2023 & 2030
• 7.2. Segment Dashboard
• 7.3. Global Clinical Trials Management System Market by Application Outlook
• 7.4. Pharmaceutical and Biotechnology Firms
  • 7.4.1. Market estimates and forecast, 2018 to 2030 (USD Million)
• 7.5. Medical Device Firms
  • 7.5.1. Market estimates and forecast, 2018 to 2030 (USD Million)
• 7.6. CROs & Others
  • 7.6.1. Market estimates and forecast, 2018 to 2030 (USD Million)

Chapter 8. Clinical Trials Management System Market: Regional Estimates & Trend Analysis, By Solution Type, By Component, By Delivery Mode, By End Use

• 8.1. Regional Market Share Analysis, 2023 & 2030
• 8.2. Regional Market Dashboard
• 8.3. Global Regional Market Snapshot
• 8.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030
• 8.5. North America
  • 8.5.1. U.S.
    • 8.5.1.1. Key country dynamics
    • 8.5.1.2. Regulatory framework/ reimbursement structure
    • 8.5.1.3. Competitive scenario
    • 8.5.1.4. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.5.2. Canada
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. Regulatory framework/ reimbursement structure
    • 8.5.2.3. Competitive scenario
    • 8.5.2.4. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
• 8.6. Europe
  • 8.6.1. UK
    • 8.6.1.1. Key country dynamics
    • 8.6.1.2. Regulatory framework/ reimbursement structure
    • 8.6.1.3. Competitive scenario
    • 8.6.1.4. UK market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.6.2. Germany
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Regulatory framework/ reimbursement structure
    • 8.6.2.3. Competitive scenario
    • 8.6.2.4. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.6.3. France
    • 8.6.3.1. Key country dynamics
    • 8.6.3.2. Regulatory framework/ reimbursement structure
    • 8.6.3.3. Competitive scenario
    • 8.6.3.4. France market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.6.4. Italy
    • 8.6.4.1. Key country dynamics
    • 8.6.4.2. Regulatory framework/ reimbursement structure
    • 8.6.4.3. Competitive scenario
    • 8.6.4.4. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.6.5. Spain
    • 8.6.5.1. Key country dynamics
    • 8.6.5.2. Regulatory framework/ reimbursement structure
    • 8.6.5.3. Competitive scenario
    • 8.6.5.4. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.6.6. Denmark
    • 8.6.6.1. Key country dynamics
    • 8.6.6.2. Regulatory framework/ reimbursement structure
    • 8.6.6.3. Competitive scenario
    • 8.6.6.4. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.6.7. Sweden
    • 8.6.7.1. Key country dynamics
    • 8.6.7.2. Regulatory framework/ reimbursement structure
    • 8.6.7.3. Competitive scenario
    • 8.6.7.4. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.6.8. Norway
    • 8.6.8.1. Key country dynamics
    • 8.6.8.2. Regulatory framework/ reimbursement structure
    • 8.6.8.3. Competitive scenario
    • 8.6.8.4. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
• 8.7. Asia Pacific
  • 8.7.1. Japan
    • 8.7.1.1. Key country dynamics
    • 8.7.1.2. Regulatory framework/ reimbursement structure
    • 8.7.1.3. Competitive scenario
    • 8.7.1.4. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.7.2. China
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Regulatory framework/ reimbursement structure
    • 8.7.2.3. Competitive scenario
    • 8.7.2.4. China market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.7.3. India
    • 8.7.3.1. Key country dynamics
    • 8.7.3.2. Regulatory framework/ reimbursement structure
    • 8.7.3.3. Competitive scenario
    • 8.7.3.4. India market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.7.4. Australia
    • 8.7.4.1. Key country dynamics
    • 8.7.4.2. Regulatory framework/ reimbursement structure
    • 8.7.4.3. Competitive scenario
    • 8.7.4.4. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.7.5. South Korea
    • 8.7.5.1. Key country dynamics
    • 8.7.5.2. Regulatory framework/ reimbursement structure
    • 8.7.5.3. Competitive scenario
    • 8.7.5.4. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.7.6. Thailand
    • 8.7.6.1. Key country dynamics
    • 8.7.6.2. Regulatory framework/ reimbursement structure
    • 8.7.6.3. Competitive scenario
    • 8.7.6.4. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
• 8.8. Latin America
  • 8.8.1. Brazil
    • 8.8.1.1. Key country dynamics
    • 8.8.1.2. Regulatory framework/ reimbursement structure
    • 8.8.1.3. Competitive scenario
    • 8.8.1.4. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.8.2. Mexico
    • 8.8.2.1. Key country dynamics
    • 8.8.2.2. Regulatory framework/ reimbursement structure
    • 8.8.2.3. Competitive scenario
    • 8.8.2.4. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.8.3. Argentina
    • 8.8.3.1. Key country dynamics
    • 8.8.3.2. Regulatory framework/ reimbursement structure
    • 8.8.3.3. Competitive scenario
    • 8.8.3.4. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
• 8.9. MEA
  • 8.9.1. South Africa
    • 8.9.1.1. Key country dynamics
    • 8.9.1.2. Regulatory framework/ reimbursement structure
    • 8.9.1.3. Competitive scenario
    • 8.9.1.4. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.9.2. Saudi Arabia
    • 8.9.2.1. Key country dynamics
    • 8.9.2.2. Regulatory framework/ reimbursement structure
    • 8.9.2.3. Competitive scenario
    • 8.9.2.4. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.9.3. UAE
    • 8.9.3.1. Key country dynamics
    • 8.9.3.2. Regulatory framework/ reimbursement structure
    • 8.9.3.3. Competitive scenario
    • 8.9.3.4. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.9.4. Kuwait
    • 8.9.4.1. Key country dynamics
    • 8.9.4.2. Regulatory framework/ reimbursement structure
    • 8.9.4.3. Competitive scenario
    • 8.9.4.4. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Recent Developments & Impact Analysis, By Key Market Participants
• 9.2. Company/Competition Categorization
  • 9.2.1. Innovators
• 9.3. Vendor Landscape
  • 9.3.1. List of key distributors and channel partners
  • 9.3.2. Key customers
  • 9.3.3. Key company market share analysis, 2023
  • 9.3.4. IQVIA, Inc.
    • 9.3.4.1. Company overview
    • 9.3.4.2. Financial performance
    • 9.3.4.3. Product benchmarking
    • 9.3.4.4. Strategic initiatives
  • 9.3.5. Medidata (Dassault Systemes)
    • 9.3.5.1. Company overview
    • 9.3.5.2. Financial performance
    • 9.3.5.3. Product benchmarking
    • 9.3.5.4. Strategic initiatives
  • 9.3.6. Oracle
    • 9.3.6.1. Company overview
    • 9.3.6.2. Financial performance
    • 9.3.6.3. Product benchmarking
    • 9.3.6.4. Strategic initiatives
  • 9.3.7. DATATRAK International, Inc.
    • 9.3.7.1. Company overview
    • 9.3.7.2. Financial performance
    • 9.3.7.3. Product benchmarking
    • 9.3.7.4. Strategic initiatives
  • 9.3.8. Clario
    • 9.3.8.1. Company overview
    • 9.3.8.2. Financial performance
    • 9.3.8.3. Product benchmarking
    • 9.3.8.4. Strategic initiatives
  • 9.3.9. SimpleTrials
    • 9.3.9.1. Company overview
    • 9.3.9.2. Financial performance
    • 9.3.9.3. Product benchmarking
    • 9.3.9.4. Strategic initiatives
  • 9.3.10. Calyx (formerly Parexel Informatics)
    • 9.3.10.1. Company overview
    • 9.3.10.2. Financial performance
    • 9.3.10.3. Product benchmarking
    • 9.3.10.4. Strategic initiatives
  • 9.3.11. RealTime Software Solutions, LLC
    • 9.3.11.1. Company overview
    • 9.3.11.2. Financial performance
    • 9.3.11.3. Product benchmarking
    • 9.3.11.4. Strategic initiatives
  • 9.3.12. Laboratory Corporation of America Holdings
    • 9.3.12.1. Company overview
    • 9.3.12.2. Financial performance
    • 9.3.12.3. Product benchmarking
    • 9.3.12.4. Strategic initiatives
  • 9.3.13. Veeva Systems
    • 9.3.13.1. Company overview
    • 9.3.13.2. Financial performance
    • 9.3.13.3. Product benchmarking
    • 9.3.13.4. Strategic initiatives
  • 9.3.14. Wipro Limited
    • 9.3.14.1. Company overview
    • 9.3.14.2. Financial performance
    • 9.3.14.3. Product benchmarking
    • 9.3.14.4. Strategic initiatives
  • 9.3.15. PHARMASEAL International Ltd
    • 9.3.15.1. Company overview
    • 9.3.15.2. Financial performance
    • 9.3.15.3. Product benchmarking
    • 9.3.15.4. Strategic initiatives